Hansoh Pharmaceutical Group Company Limited (HNSPF)
OTCMKTS
· Delayed Price · Currency is USD
5.00
0.00 (0.00%)
Dec 4, 2025, 4:00 PM EST
HNSPF Revenue
Hansoh Pharmaceutical Group Company had revenue of 7.43B CNY in the half year ending June 30, 2025, with 64.78% growth. This brings the company's revenue in the last twelve months to 13.19B, up 9.02% year-over-year. In the year 2024, Hansoh Pharmaceutical Group Company had annual revenue of 12.26B with 21.35% growth.
Revenue (ttm)
13.19B CNY
Revenue Growth
+9.02%
P/S Ratio
17.72
Revenue / Employee
1.47M CNY
Employees
8,989
Market Cap
32.62B USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 122.89M |
| Glass House Brands | 196.17M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 937.00K |
| Silence Therapeutics | 25.83M |
| Global Cord Blood | 196.10M |
| Zomedica | 29.45M |